# Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy

> **NCT06784479** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Dan Liu** · enrollment: 174 (actual)

## Conditions studied

- Sedative Effect During Drug-induced Sleep Endoscopy
- Obstructive Sleep Apnea (OSA)

## Interventions

- **DRUG:** Remimazolam and Propofol
- **DRUG:** Propofol
- **DRUG:** Midazolam and propofol

## Key facts

- **NCT ID:** NCT06784479
- **Lead sponsor:** Dan Liu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06784479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06784479, "Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06784479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*